C
MDGL icon

Covestor’s Madrigal Pharmaceuticals MDGL Stock Holding History

Covestor’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Sell
128
-16
-11% -$8.2K 0.04% 597
2026
Q1 		$76K Sell
144
-165
-53% -$78.8K 0.05% 429
2025
Q4 		$180K Buy
309
+268
+654% +$137K 0.09% 265
2025
Q3 		$19K Hold
41
– – 0.01% 1292
2025
Q2 		$13K Sell
41
-1
-2% -$298 0.01% 1415
2025
Q1 		$14K Hold
42
– – 0.01% 1314
2024
Q4 		$13K Hold
42
– – 0.01% 1391
2024
Q3 		$9K Hold
42
– – 0.01% 1619
2024
Q2 		$12K Buy
42
+1
+2% +$238 0.01% 1417
2024
Q1 		$11K Sell
41
-24
-37% -$5.66K 0.01% 1520
2023
Q4 		$15K Buy
65
+38
+141% +$6.65K 0.01% 1306
2023
Q3 		$4K Hold
27
– – ﹤0.01% 1743
2023
Q2 		$6K Sell
27
-1
-4% -$271 ﹤0.01% 1680
2023
Q1 		$7K Buy
28
+26
+1,300% +$7.08K 0.01% 1472
2022
Q4 		$1K Hold
2
– – ﹤0.01% 1898
2022
Q3 		$0 Sell
2
-1
-33% -$69 ﹤0.01% 2344
2022
Q2 		$0 Hold
3
– – ﹤0.01% 2175
2022
Q1 		$0 Sell
3
-1
-25% -$84 ﹤0.01% 2301
2021
Q4 		$0 Buy
+4
New +$329 ﹤0.01% 2222

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Covestor's MDGL Position: Q2 2026 in Review

Covestor reduced its Madrigal Pharmaceuticals (MDGL) stake by 11% in Q2 2026, selling an estimated $8.2K and leaving 128 shares worth $69K. The position accounts for 0.04% of the portfolio, ranked #597.

Covestor first reported a position in MDGL in Q4 2021 and has held it in 19 quarters since. The position peaked at $180K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Covestor held 128 shares of Madrigal Pharmaceuticals worth $69K as of Q2 2026.
  • Covestor sold 16 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $8.2K.
  • Madrigal Pharmaceuticals made up 0.04% of Covestor's portfolio in Q2 2026, its #597 holding.
  • Covestor first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Madrigal Pharmaceuticals position peaked at $180K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.